CompletedPhase 1ketamine

Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery

Sponsored by Assiut University

NCT ID
NCT02462681
Target Enrollment
90 participants
Start Date
2015-05
Est. Completion
2017-06

About This Study

This study aims to investigate the safety and the analgesic efficacy of adding Ketamine to bupivacaine 0.25% in thoracic PVB in patients undergoing modified radical mastectomy.

Conditions Studied

Acute PainChronic Pain

Interventions

  • •paravertebral block

Eligibility

Sex:FEMALE
Age:25 Years - 70 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* all patients scheduled for elective modified radical mastectomy with axillary dissection will be enrolled in the study

Exclusion Criteria:

* patients with a known allergy to the study drugs
* patients with bleeding diathesis
* patients with infection at the site of injection
* patients with central neuropathy
* patients with liver impairment
* patients with renal impairment
* drugs or alcohol abusers
* patients with psychiatric illnesses

Study Locations (1)

Assiut University
Asyut, Egypt

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery | Huxley